IRIS Accounts Production v24.3.0.553 07597583 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false 45428 31054 56577 18999 35399 4625 66606 45428 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075975832023-04-30075975832024-04-30075975832023-05-012024-04-30075975832022-04-30075975832022-05-012023-04-30075975832023-04-3007597583ns15:EnglandWales2023-05-012024-04-3007597583ns14:PoundSterling2023-05-012024-04-3007597583ns10:Director12023-05-012024-04-3007597583ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3007597583ns10:SmallEntities2023-05-012024-04-3007597583ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3007597583ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3007597583ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3007597583ns10:FullAccounts2023-05-012024-04-3007597583ns10:Director2422023-04-3007597583ns10:Director2422022-04-3007597583ns10:Director2422023-05-012024-04-3007597583ns10:Director2422022-05-012023-04-3007597583ns10:Director2422024-04-3007597583ns10:Director2422023-04-3007597583ns10:Director22023-05-012024-04-3007597583ns10:RegisteredOffice2023-05-012024-04-3007597583ns5:CurrentFinancialInstruments2024-04-3007597583ns5:CurrentFinancialInstruments2023-04-3007597583ns5:ShareCapital2024-04-3007597583ns5:ShareCapital2023-04-3007597583ns5:RetainedEarningsAccumulatedLosses2024-04-3007597583ns5:RetainedEarningsAccumulatedLosses2023-04-3007597583ns5:PlantMachinery2023-05-012024-04-3007597583ns5:PlantMachinery2023-04-3007597583ns5:PlantMachinery2024-04-3007597583ns5:PlantMachinery2023-04-3007597583ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3007597583ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30075975831ns10:Director12023-04-30075975831ns10:Director12022-04-30075975831ns10:Director12023-05-012024-04-30075975831ns10:Director12022-05-012023-04-30075975831ns10:Director12024-04-30075975831ns10:Director12023-04-30
REGISTERED NUMBER: 07597583 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

K2 Physiocare Limited

K2 Physiocare Limited (Registered number: 07597583)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


K2 Physiocare Limited

Company Information
for the Year Ended 30 April 2024







DIRECTORS: Mr A Karstad
Mrs J Karstad





REGISTERED OFFICE: 3B Lockheed Court
Preston Farm
Stockton on Tees
TS18 3SH





REGISTERED NUMBER: 07597583 (England and Wales)





ACCOUNTANTS: JBC Accountants Limited
Chartered Accountants
3B Lockheed Court
Preston Farm
Stockton on Tees
TS18 3SH

K2 Physiocare Limited (Registered number: 07597583)

Balance Sheet
30 April 2024

30/4/24 30/4/23
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 10,616 11,041

CURRENT ASSETS
Debtors 5 75,709 49,826
Cash at bank 198,434 162,694
274,143 212,520
CREDITORS
Amounts falling due within one year 6 17,083 11,397
NET CURRENT ASSETS 257,060 201,123
TOTAL ASSETS LESS CURRENT
LIABILITIES

267,676

212,164

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 267,576 212,064
SHAREHOLDERS' FUNDS 267,676 212,164

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 January 2025 and were signed on its behalf by:





Mr A Karstad - Director


K2 Physiocare Limited (Registered number: 07597583)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

K2 Physiocare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

These financial statements for the year ended 30 April 2017 are the first financial statements that comply with FRS 102 Section 1A small entities. The date of transition is 1 May 2015.

No re-statement of the opening balances at the date of transition has been required and there have been no changes to accounting policies.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost, 20% on reducing balance and 15% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the profit and loss account.

Deferred taxation is provided on the liability method to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences.

Current and deferred tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

K2 Physiocare Limited (Registered number: 07597583)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 May 2023
and 30 April 2024 22,178
DEPRECIATION
At 1 May 2023 11,137
Charge for year 425
At 30 April 2024 11,562
NET BOOK VALUE
At 30 April 2024 10,616
At 30 April 2023 11,041

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/4/24 30/4/23
£ £
Trade debtors 4,182 4,293
Other debtors 71,527 45,533
75,709 49,826

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/4/24 30/4/23
£ £
Taxation and social security 15,085 9,598
Other creditors 1,998 1,799
17,083 11,397

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 April 2024 and 30 April 2023:

30/4/24 30/4/23
£ £
Mr A Karstad and Mrs J Karstad
Balance outstanding at start of year 45,428 31,054
Amounts advanced 56,577 18,999
Amounts repaid (35,399 ) (4,625 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 66,606 45,428

Interest has been charged on the above loan at 2.25%